News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Impact Journals at AACR Annual Meeting 2024

News

March 11, 2024
Impact Journals is proud to participate at the American Association for Cancer Research (AACR) Annual Meeting 2024, which convenes April 5-10 in San Diego, California. continue reading »

GZ17-6.02 With Proteasome Inhibitors Kills Multiple Myeloma Cells

News

March 6, 2024
PRESS RELEASE: On March 5, 2024, a new research paper was published in Oncotarget, entitled, “GZ17-6.02 interacts with proteasome inhibitors to kill multiple myeloma cells.” continue reading »

A Longitudinal Study on Dasatinib, Quercetin, and Fisetin Senolytic Interventions

News

March 6, 2024
PRESS RELEASE: A new research paper was published in Aging’s Volume 16, Issue 4, entitled, “Exploring the effects of Dasatinib, Quercetin, and Fisetin on DNA methylation clocks: a longitudinal study on senolytic interventions.” continue reading »

A Call for Standardization of Controls in Lifespan Studies

Aging

March 5, 2024
PRESS RELEASE: A new research perspective was published in Aging’s Volume 16, Issue 4, entitled, “On standardization of controls in lifespan studies.” continue reading »

Sacituzumab Govitecan Plus Platinum-based Chemotherapy in Breast, Bladder, and Lung Carcinomas

News

March 4, 2024
PRESS RELEASE: On February 22, 2024, a new research paper was published in Oncotarget, entitled, “Sacituzumab govitecan plus platinum-based chemotherapy mediates significant antitumor effects in triple-negative breast, urinary bladder, and small-cell lung carcinomas.” continue reading »